Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
Status:
Completed
Trial end date:
2019-06-18
Target enrollment:
Participant gender:
Summary
The investigator thinks that the oxytocin (OT) can improve durably and significantly the
behavior disorders and thus the socialization but also the satisfaction and could thus be an
interesting therapeutic alternative for the patients presenting a Prader-Willi Syndrome
(SPW). Although today several studies demonstrated the effects of the OT in various domains
of the behavior, the investigator do not know either its specificity of action about the
cerebral level, or its duration of action, or the optimal modalities of administration and in
particular at patients SPW.